The medication segment was the largest in 2022, favored for its cost-effectiveness and common use as a first-line treatment. .Centriacinar Emphysema Growth: The centriacinar segment, primarily linked ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

The global dyspnea treatment market, valued at USD 6.31 billion in 2023, is poised for remarkable growth, with projections ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...

a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new patient access program, in partnership with Direct Relief, to supply inhalers to ...

Inhaler have shared their hypnotic new single ‘Open Wide’ from their forthcoming album of the same name. READ MORE: Inhaler tell us about single ‘Your House’ and new album ‘Open Wide ...

Despite these benefits, inhalation drug delivery systems are still in the developmental stage, particularly for targeted local delivery. Dry powder inhalers (DPIs) have emerged as a popular choice due ...

Sales of General Medicines were up 7% during the quarter. This upside was driven by solid sales growth of the asthma inhaler Trelegy Ellipta across all regions, reflecting patient demand.

New respiratory drugs Nucala (mepolizumab) for severe asthma and Advair follow-up Trelegy (fluticasone furoate, umeclidinium, and vilanterol) made a solid supporting cast in the three-month period.

The current aerosol asthma inhalers we use are cheap but, because of the gases they contain, are one of the NHS's biggest contributions to climate change. Other countries think alternatives are ...

Alamy An inhaler similar to the one used in the budesonide trial to treat Covid in at-risk patients at home During the first two weeks of experiencing symptoms at home, 751 were given an inhaler ...